BIOMAT Database Logo BIOMAT Database Logo

Prevalence of HTLV-III/LAV antibodies among Haitians. 1985

A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche

UI MeSH Term Description Entries
D006205 Haiti A republic in the Greater Antilles in the West Indies. Its capital is Port-au-Prince. With the Dominican Republic it forms the island of Hispaniola - Haiti occupying the western third and the Dominican Republic, the eastern two thirds. Haiti belonged to France from 1697 until its rule was challenged by slave insurrections from 1791. It became a republic in 1820. It was virtually an American protectorate from 1915 to 1934. It adopted its present constitution in 1964 and amended it in 1971. The name may represent either of two Caribbean words, haiti, mountain land, or jhaiti, nest. (From Webster's New Geographical Dictionary, 1988, p481 & Room, Brewer's Dictionary of Names, 1992, p225)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
The prevalence of HTLV-III/LAV antibodies in heterosexuals.
April 1986, JAMA,
A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
LAV/HTLV-III and sperm antibodies.
December 1986, Fertility and sterility,
A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
Antibodies to HTLV-III/LAV among aboriginal Amazonian Indians in Venezuela.
November 1985, Lancet (London, England),
A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
HTLV-III/LAV antibodies in contacts of hemophiliacs.
June 1986, JAMA,
A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
LAV/HTLV-III and HTLV-I antibodies in hemodialysis patients.
January 1986, Nephron,
A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
[Anti-HTLV-III/LAV antibodies in hematology reactives].
January 1986, Sangre,
A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
LAV/HTLV-III antibodies in connective tissue diseases.
September 1985, Lancet (London, England),
A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle.
May 1986, American journal of public health,
A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
[LAV/HTLV-III antibodies in blood and blood products].
October 1985, Deutsche medizinische Wochenschrift (1946),
A E Pitchenik, and T J Spira, and R Elie, and M A Fischl, and J P Getchell, and E Arnoux, and G D Pierre, and A C Laroche, and J M Guerin, and R Malebranche
Prevalence of HBV HDV and LAV/HTLV-III infections among Greek drug addicts.
January 1987, Progress in clinical and biological research,
Copied contents to your clipboard!